Omalizumab, alone or with allergen immunotherapy for house dust mites, may reduce daily use of inhaled corticosteroids in patients with house dust mite-sensitized mild-to-moderate allergic asthma.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/omalizumab-plus-immunotherapy-may-ease-house-dust-mite-2026a1000czi?src=rss
Author :
Publish date : 2026-04-23 21:24:00
Copyright for syndicated content belongs to the linked Source.
